Depolymerised holothurian glycosaminoglycan(Suzhou Ronnsi Pharma)

Product Name :
Depolymerised holothurian glycosaminoglycan(Suzhou Ronnsi Pharma)

Search keywords :
CD62P

drugId :
null

Target Vo:
P-selectin

Target Vo Short Name :
SELP

Moa_Name:
Angiogenesis inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Suzhou Rongxi Biotechnology Co Ltd

Active Company_Name :

Active Indication_Name:
Thrombosis

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
TrkA Antibody
HIF1 beta Antibody
BRD2 Antibody: BRD2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 88 kDa, targeting to BRD2. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts